Incidence and Risk Factors of Ocular Complications Among Patients With Homocystinuria

NCT06545305 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-08-13

No results posted yet for this study

Summary

Background: Cysteine beta-synthase (CBS) deficiency, often known as classic homocystinuria (HCU), is an uncommon inborn mistake in methionine metabolism. Developmental delay, intellectual incapacity, skeletal and vascular symptoms, and ocular abnormalities are possible main clinical characteristics.

Objective: This study sought to describe the ocular anomalies that King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia, HCU patients presented with between 2018 and 2022.

Conditions

  • Complications

Interventions

PROCEDURE

Lensectomy and vitrectomy

Corrections

Sponsors & Collaborators

  • King Fahad Armed Forces Hospital

    lead OTHER_GOV

Principal Investigators

  • Hassan A Ahmed, MS · Pediatric Department, King Salman Medical city-Maternity and Children, Medina, Saudi Arabia

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-07-01
Completion
2024-08-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06545305 on ClinicalTrials.gov